SECOND AMENDMENT TO UNSECURED CREDIT AGREEMENT
Exhibit 10.4
SECOND AMENDMENT TO UNSECURED CREDIT AGREEMENT
This Second Amendment to Unsecured Credit Agreement (the “Amendment”) is made as of August 2, 2012 (the “Effective Date”), by and among BIOMED REALTY, L.P., a Maryland limited partnership (“Borrower”), KEYBANK NATIONAL ASSOCIATION, as “Administrative Agent,” and such of the lenders (“Lenders”) party to the Loan Agreement (defined below) constituting the Requisite Lenders under the Loan Agreement, and, solely for the purpose of agreeing to the terms and conditions of Section 6 below, BIOMED REALTY TRUST, INC., a Maryland corporation (“Guarantor”).
R E C I T A L S
A. Borrower, Administrative Agent, the Lenders executing this Amendment and certain other Lenders have entered into that certain Unsecured Credit Agreement dated as of July 14, 2011, as amended by that certain First Amendment to Unsecured Credit Agreement dated as of March 30, 2012 (as it may be further amended, the “Loan Agreement”). All capitalized terms used herein and not otherwise defined shall have the meanings given to them in the Loan Agreement.
B. Borrower has requested that Administrative Agent and Lenders agree to amend the Loan Agreement as provided herein.
NOW, THEREFORE, with reference to the foregoing Recitals, all of which are incorporated herein by this reference, for valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
AGREEMENTS
1. Amendments to Defined Terms. The following Definitions from Article 1 of the Loan Agreement are modified as follows:
A. The defined term “Project” is hereby deleted and replaced with the following:
“Project” means any parcel of real property located in (i) the 48 states that comprise the continental United States of America, or (ii) the District of Columbia, or (iii) the United Kingdom, or (iv) France, or (v) Germany, or (vi) Switzerland, which in each case is owned, leased or operated (in each case in whole or in part) by Borrower, or any of its Subsidiaries or Investment Affiliates and which is improved with a building or buildings primarily used or intended to be used for office, office/laboratory, research, warehouse or manufacturing purposes or other ancillary purposes such as a parking garage serving or in the vicinity of any such building.
B. The defined term “Total Unencumbered Asset Value” is hereby deleted and replaced with the following:
“Total Unencumbered Asset Value” means, as of any day, an amount equal to the sum of the following amounts for assets then owned or leased under a Mortgageable Ground Lease by a member of the Consolidated Group or an Investment Affiliate and valued as follows: (i) Adjusted NOI attributable to Unencumbered Projects that are wholly owned in fee simple (or wholly leased under a Mortgageable Ground Lease) by Borrower or a Wholly-Owned Subsidiary of Borrower divided by the Capitalization Rate (excluding, however, for purposes of this clause (i) and the following clauses (ii) and (iii) any such portion of such Adjusted NOI attributable to (a) Unencumbered Projects that were Unstabilized Projects at any time during the Fiscal Quarter with respect to which Adjusted NOI is determined, (b) Unencumbered Projects acquired after the first day of such Fiscal Quarter, or (c) Unencumbered Projects disposed of during or after such Fiscal Quarter); plus, without duplication (ii) the BioMed Pro Rata Share of Adjusted NOI attributable to Unencumbered Projects that are wholly owned in fee simple (or wholly leased under a Mortgageable Ground Lease, or a combination of owned in fee simple and leased under a Mortgageable Ground Lease) by a member of the Consolidated Group other than Borrower or a Wholly-Owned Subsidiary of Borrower, divided by the Capitalization Rate; plus (iii) the Consolidated Group Pro Rata Share of Adjusted NOI attributable to Unencumbered Projects that are wholly owned in fee simple (or wholly leased under a Mortgageable Ground Lease) by an Investment Affiliate, divided by the Capitalization Rate, provided that in the case of clauses (ii) and (iii), if the aggregate amount to be contributed to Total Unencumbered Asset Value on account of the Unencumbered Projects described therein would exceed ten percent (10%) of Total Unencumbered Asset Value, the excess of such aggregate contribution over such maximum percentage shall be excluded; plus (iv) with respect to Unencumbered Projects excluded from clauses (i), (ii) and (iii) because they are Unstabilized Projects, the greater of (a) the portion of such Adjusted NOI attributable to such Unstabilized Projects (or the BioMed Pro Rata Share or Consolidated Group Pro Rata Share, as the case may be, thereof with respect to any such Unstabilized Project owned by a member of the Consolidated Group other than Borrower or a Wholly-Owned Subsidiary of Borrower or owned by an Investment Affiliate), divided by the Capitalization Rate; and (b) the Consolidated Group’s GAAP cost basis (or the BioMed Pro Rata Share or Consolidated Group Pro Rata Share, as the case may be, thereof with respect to any such Unstabilized Project owned by a member of the Consolidated Group other than Borrower or a Wholly-Owned Subsidiary of Borrower or owned by Investment Affiliate) in such Unstabilized Project, provided that, in the case of clause (iv), if the amount to be contributed to Total Unencumbered Asset Value on account of the Unencumbered Projects described in such clause would exceed ten percent (10%) of Total Unencumbered Asset Value, the excess of such contribution over such maximum percentage shall be excluded; plus (v) the Consolidated Group’s GAAP cost basis (or the BioMed Pro Rata Share or Consolidated Group Pro Rata Share, as the case may be, thereof with respect to any such unencumbered land parcel owned by a member of the Consolidated Group other than Borrower or a Wholly-Owned Subsidiary of Borrower or by an Investment Affiliate) of all unencumbered land parcels, provided that, in the case of clause (v), if the amount to be contributed to Total Unencumbered Asset Value on account of the unencumbered land parcels described in such clause would exceed five percent (5%) of Total Unencumbered Asset Value, the excess of such contribution over such maximum percentage shall be excluded; plus (vi) the acquisition cost of all Unencumbered Projects acquired after the first day of the most recent Fiscal Quarter for which Adjusted NOI has been reported and on or prior to such date of determination (or the BioMed Pro Rata Share or Consolidated Group Pro Rata Share, as the case may be, of such acquisition cost with respect to any Unencumbered Project acquired by a member of the Consolidated Group other than Borrower or a Wholly-Owned Subsidiary of Borrower or by an Investment Affiliate),
- 2 -
provided that with respect to each of the foregoing clauses of this sentence, if (X) the amount to be contributed to Total Unencumbered Asset Value on account of any single Unencumbered Project would exceed twenty percent (20%) of Total Unencumbered Asset Value, the excess of such contribution over such maximum percentage shall be excluded and (Y) the amount to be contributed to Total Unencumbered Asset Value on account of Foreign Projects would, in the aggregate, exceed fifteen percent (15%) of Total Unencumbered Asset Value, the excess of such contribution(s) over such maximum percentage shall be excluded. For purposes of determining Total Unencumbered Asset Value, Unencumbered Projects with negative Adjusted NOI, shall be excluded from clauses (i), (ii) or (iii) above.
C. The defined term “Unsecured Term Credit Agreement” is hereby deleted and replaced with the following:
“Unsecured Term Credit Agreement” means that certain Unsecured Credit Agreement dated as of March 30, 2012 by and among the Borrower, KeyBank and certain other lenders identified therein, as amended by that certain First Amendment to Unsecured Credit Agreement dated as of August 2, 2012, as it may be further amended or modified from time to time.
2. Additional Defined Terms. Article 1 of the Loan Agreement is hereby amended by the addition of the following new defined terms having the following meanings as provided herein:
A. “Dollar Equivalent” means on any date of determination, for the purposes of determining compliance with Article 5 or Article 6 or the existence of an Event of Default under Article 9 with respect to any amount denominated in a currency other than Dollars, the equivalent in Dollars of such amount, determined in good faith by the Borrower in a manner consistent with the way such amount is or would be reflected on the Borrower’s audited consolidated financial statements for the fiscal year in which such determination is made.
B. “Domestic Project” means any Project located in the 48 states that comprise the continental United States of America or in the District of Columbia.
C. “Foreign Project” means any Project located in (i) the United Kingdom, or (ii) France, or (iii) Germany, or (iv) Switzerland.
3. Amendments to Loan Agreement. The Loan Agreement is hereby amended as follows:
A. Dollar Equivalent. The following shall be added as new Section 1.6 to the Loan Agreement:
“1.6. Dollar Equivalent. Notwithstanding anything contained herein to the contrary, for purposes of any determination under Article 4, Article 5 or Article 6, all amounts incurred, outstanding or proposed to be incurred or outstanding in currencies other than Dollars shall be translated into the Dollar Equivalents of such amounts.”
- 3 -
B. Interpretation of Terms. Section 11.2 of the Credit Agreement “[Intentionally Omitted]” is hereby deleted in its entirety and replaced with the following:
11.2. Interpretation of Terms. The parties to this Agreement agree that the following terms used herein shall have the correlative meanings ascribed to such terms or concepts in the United Kingdom:
(i) “leasehold mortgage”;
(ii) “fee simple”;
(iii) “fee owner”;
(iv) “first mortgage financing”;
(v) “Phase I report”; and
(vi) “Phase II report”.
4. Total Unencumbered Asset Value Calculation. As of the Effective Date, Schedule 3 to Exhibit B (Total Unencumbered Asset Value Calculation) to the Loan Agreement is hereby deleted in its entirety and replaced with the attached Schedule 3 to Exhibit B.
5. Schedule of Subsidiaries and Projects. As of the Effective Date, Schedule 4.4 (Subsidiaries) and Schedule 4.19 (Projects) to the Loan Agreement are hereby deleted in their entirety and replaced with the attached Schedule 4.4 and Schedule 4.19.
6. Guarantor. Guarantor (a) consents to the terms and conditions of this Amendment; and (b) reaffirms the Guaranty and confirms and agrees that, notwithstanding this Amendment and consummation of the transactions contemplated thereby, the Guaranty and all of such Guarantor’s covenants, obligations, agreements, waivers, and liabilities set forth in the Guaranty continue in full force and effect in accordance with their terms, modified only to the extent specifically set forth in this Amendment.
7. Full Force and Effect. Except as amended hereby, the terms and provisions of the Loan Agreement and the Loan Documents remain unchanged, are and shall remain in full force and effect unless and until modified or amended in writing in accordance with their terms, and are hereby ratified and confirmed. Except as expressly provided herein, this Amendment shall not constitute an amendment, waiver, consent or release with respect to any provision of any Loan Document, a waiver of any default or Event of Default under any Loan Document, or a waiver or release of any of the Lenders’ rights and remedies (all of which are hereby reserved). The Borrower expressly ratifies and confirms the confession of judgment (if applicable) and waiver of jury trial provisions contained in the Loan Documents.
8. References to Loan Documents; Capitalized Terms. Any and all references to any Loan Document in any other Loan Document shall be deemed to refer to such Loan Document as amended by this Amendment. This Amendment is deemed incorporated into each of the Loan Documents. Any initially capitalized terms used in this Amendment without definition shall have the meanings assigned to those terms in the Loan Documents. To the extent that any term or provision of this Amendment is or may be inconsistent with any term or provision in any Loan Document, the terms and provisions of this Amendment shall control.
- 4 -
9. Successors and Assigns. This Amendment will be binding upon and inure to the benefit of the Borrower and the Lenders and their respective heirs, executors, administrators, successors and assigns.
10. Governing Law. This Amendment shall be governed by and construed in accordance with the laws of the State of New York.
11. Conditions to Effectiveness. This Amendment shall not be effective until each of the following conditions precedent have been fulfilled to the satisfaction of the Administrative Agent:
(a) The Administrative Agent shall have received counterparts of this Amendment duly executed and delivered by each of the parties hereto; and
(b) The Administrative Agent shall have received such certificates of resolutions or other action, incumbency certificates and/or other certificates of the Borrower, as Administrative Agent may require evidencing the identity, authority and capacity of each officer of the Borrower authorized to act in connection with this Amendment.
12. Representations and Warranties. The Borrower hereby represents and warrants to the Administrative Agent and the Lenders as of the date hereof that (i) the representations and warranties of Borrower, contained in Article 4 of the Loan Agreement (as amended by this Amendment) are true and correct in all material respects and (ii) no Event of Default or Default has occurred and is continuing.
13. Counterparts. This Amendment may be executed in any number of counterparts, all of which taken together shall constitute one agreement, and any of the parties hereto may execute this Amendment by signing any such counterpart.
[Remainder of Page Left Intentionally Blank.]
- 5 -
IN WITNESS WHEREOF, the parties have executed and delivered this Amendment as of the date first written above.
| BORROWER: | ||||
| BIOMED REALTY, L.P., a Maryland limited partnership | ||||
| By: |
BioMed Realty Trust, Inc., its sole | |||
| General Partner | ||||
| By: | /s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇ | |||
|
| ||||
| Name: | ▇▇▇▇▇▇ ▇▇▇▇▇▇ | |||
| Title: | Vice President, Finance | |||
| Address: | ||||
| BioMed Realty, L.P. ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ | ||||
| ▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||||
| Attn: Vice President, Real Estate Counsel | ||||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||||
| GUARANTOR (solely with respect to Section 6): | ||||
| BIOMED REALTY TRUST, INC., a Maryland corporation | ||||
| By: |
/s/ ▇▇▇▇▇▇ ▇▇▇▇▇▇ | |||
|
|
| |||
| Name: |
▇▇▇▇▇▇ ▇▇▇▇▇▇ | |||
| Title: |
Vice President, Finance | |||
| Address: | ||||
| BioMed Realty, L.P. ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ | ||||
| ▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||||
| Attn: Vice President, Real Estate Counsel | ||||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||||
Signature Page
| ADMINISTRATIVE AGENT: | ||
| KEYBANK NATIONAL ASSOCIATION, as Administrative Agent | ||
| By: | /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | |
| Print Name: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | ||
| Title: Vice President | ||
| Address: | ||
| KeyBank—Real Estate Capital | ||
| ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇ | ||
| Mail Code: OH-01-27-0839 | ||
| ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | ||
| LENDERS: | ||
| KEYBANK NATIONAL ASSOCIATION, individually and as Administrative Agent | ||
| By: | /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | |
| Print Name: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | ||
| Title: Vice President | ||
| Address: | ||
| KeyBank—Real Estate Capital | ||
| ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇ | ||
| Mail Code: OH-01-27-0839 | ||
| ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Phone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | ||
Signature Page
| ▇▇▇▇▇ FARGO BANK, N.A., individually and | ||
| as Syndication Agent | ||
| By: | /s/ ▇▇▇▇ ▇▇▇▇▇▇▇ | |
|
| ||
| Print Name: ▇▇▇▇ ▇▇▇▇▇▇▇ | ||
| Title: Vice President | ||
| Address: | ||
| ▇▇▇▇▇ Fargo Bank, N.A. | ||
| ▇▇▇ ▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇ | ||
| ▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇ ▇▇▇▇▇▇▇, Vice President | ||
Signature Page
| U.S. BANK NATIONAL ASSOCIATION, | ||
| a national banking association, individually and as Documentation Agent | ||
| By: | /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇ | |
| Name: ▇▇▇▇▇▇▇ ▇▇▇▇▇ | ||
| Title: Senior Vice President | ||
| Address: | ||
| U.S. Bank National Association | ||
| ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇ | ||
| ▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇▇▇▇ ▇▇▇▇▇ | ||
Signature Page
| ▇▇▇▇▇▇▇ ▇▇▇▇▇ BANK, N.A. | ||
| By: | /s/ ▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇ | |
| Print Name: ▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇ | ||
| Title: Senior Vice President | ||
| Address: | ||
| ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ | ||
| ▇▇. ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | ||
Signature Page
| UBS LOAN FINANCE LLC | ||
| By: | /s/ ▇▇▇▇ ▇. ▇▇▇▇ | |
| Print Name: ▇▇▇▇ ▇. ▇▇▇▇ | ||
| Title: Associate Director | ||
| By: | /s/ ▇▇▇▇ ▇. ▇▇▇▇▇ | |
| Print Name: ▇▇▇▇ ▇. ▇▇▇▇▇ | ||
| Title: Associate Director | ||
| Address: | ||
| ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ | ||
| ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: Banking Products Services | ||
Signature ▇▇▇▇
| ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ BANK, N.A. | ||
| By: |
/s/ ▇▇▇▇ ▇▇▇▇▇▇▇ | |
| Print Name: ▇▇▇▇ ▇▇▇▇▇▇▇ | ||
| Title: Authorized Signatory | ||
|
By: | ||
|
Print Name: | ||
|
Title: | ||
| Address: | ||
| One Utah Center | ||
| ▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇ | ||
| ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | ||
| And to: | ||
| ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ Loan Servicing | ||
| ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇ | ||
| ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
Signature Page
| DEUTSCHE BANK TRUST COMPANY | ||
| AMERICAS | ||
| By: |
/s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇ | |
| Print Name: ▇▇▇▇▇ ▇▇▇▇▇▇▇ | ||
| Title: Managing Director | ||
| By: |
/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ | |
| Print Name: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇ | ||
| Title: Director | ||
| Address: | ||
| Deutsche Bank Securities, Inc. | ||
| ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ | ||
| ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇▇ ▇▇▇▇▇, Director | ||
Signature Page
| SUMITOMO MITSUI BANKING CORPORATION | ||
| By: |
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇ | |
| Print Name: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇ | ||
| Title: General Manager | ||
| Address: | ||
| ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇ | ||
| ▇▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇.▇. ▇▇▇▇▇ | ||
Signature Page
| RBS CITIZENS, N.A. | ||
| By: | /s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | |
| Print Name: ▇▇▇▇▇▇ ▇. ▇▇▇▇▇ | ||
| Title: Senior Vice President | ||
| Address: | ||
| RBS Citizens, N.A. | ||
| ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ | ||
| ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇.▇. ▇▇▇▇▇ | ||
Signature Page
| REGIONS BANK | ||
| By: | /s/ ▇▇▇▇ ▇. ▇▇▇▇▇▇ | |
| Print Name: ▇▇▇▇ ▇. ▇▇▇▇▇▇ | ||
| Title: Vice President | ||
| Address: | ||
| ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇, ▇▇▇▇▇ ▇▇▇ | ||
| ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇ ▇▇▇▇▇▇, Vice President | ||
Signature Page
| PNC BANK, NATIONAL ASSOCIATION | ||
| By: | /s/ ▇▇▇▇▇ ▇▇▇▇▇ | |
| Print Name: ▇▇▇▇▇ ▇▇▇▇▇ | ||
| Title: Vice President | ||
| Address: | ||
| c/o PNC Real Estate | ||
| ▇▇▇ ▇▇▇▇▇▇ ▇▇, ▇▇▇▇ ▇▇▇▇▇ | ||
| Mailstop XX-XMSF-28-1 | ||
| ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
Signature Page
| COMERICA BANK | ||
| By: | /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ | |
| Print Name: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ | ||
| Title: Vice President | ||
| Address: | ||
| ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇ | ||
| ▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, Vice President | ||
Signature Page
| TD BANK, N.A. | ||
| By: | /s/ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ | |
| Print Name: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ | ||
| Title: Vice President | ||
| Address: | ||
| Commercial Real Estate Lending | ||
| TD Bank, N.A. | ||
| ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇ | ||
| ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇, Vice President | ||
Signature Page
| SOVEREIGN BANK | ||
| By: | /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | |
| Print Name: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | ||
| Title: Senior Vice President | ||
| Address: | ||
| ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ | ||
| ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇ ▇▇▇▇, Credit Officer | ||
Signature Page
| THE BANK OF EAST ASIA, LIMITED, LOS ANGELES BRANCH | ||
| By: | /s/ ▇▇▇▇▇ ▇▇▇ | |
| Print Name: ▇▇▇▇▇ ▇▇▇ | ||
| Title: Vice President and Credit Manager | ||
| By: | /s/ ▇▇▇▇▇ ▇▇▇ | |
| Print Name: ▇▇▇▇▇ ▇▇▇ | ||
| Title: EVP & Chief Lending Officer | ||
| Address: | ||
| ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ | ||
| ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||
| Attention: ▇▇▇▇▇▇▇▇ ▇▇▇ | ||
Signature Page
| MEGA INTERNATIONAL COMMERCIAL BANK CO., LTD. NEW YORK BRANCH | ||||
| By: | /s/ ▇▇▇▇ ▇▇▇▇▇ | |||
| Printed Name: ▇▇▇▇ ▇▇▇▇▇ | ||||
| Title: VP & Deputy GM | ||||
| Address: | ||||
| ▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ | ||||
| ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||||
| Telephone: (▇▇▇) ▇▇▇-▇▇▇▇ | ||||
| Facsimile: (▇▇▇) ▇▇▇-▇▇▇▇ | ||||
| Attention: ▇▇▇▇ ▇▇▇▇ | ||||
Signature Page
| ▇▇▇▇▇ ▇▇▇ COMMERCIAL BANK, LTD., NEW YORK BRANCH | ||
| By: | /s/ ▇▇▇▇ ▇.▇. ▇▇▇▇ | |
| Print Name: ▇▇▇▇ ▇.▇. ▇▇▇▇ | ||
| Title: Vice President and General Manager | ||
| Address: | ||
| ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ | ||
| ▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ | ||
Signature Page
SCHEDULE 3 TO EXHIBIT B
Contributions of Unencumbered Projects to Total Unencumbered Asset Value (All amounts previously multiplied by BioMed Pro Rata Share or Consolidated Group Pro Rata Share where applicable)
| Property Description |
Adjusted NOI* |
Applicable Capitalization Rate |
Cost Basis or Acquisition Cost ** |
Contribution to Total Unencumbered Asset Value Before Reductions |
||||||||
| 1. |
$ | $ | $ | |||||||||
| 2. |
$ | $ | $ | |||||||||
| . |
$ | $ | $ | |||||||||
| $ | ||||||||||||
| Single Project Concentration Reduction*** |
($ | ) | ||||||||||
| Non-Wholly Owned Reduction**** |
($ | ) | ||||||||||
| Unstabilized Project Reduction***** |
($ | ) | ||||||||||
| Unencumbered Land Parcel Reduction****** |
($ | ) | ||||||||||
| Foreign Project Reduction******* |
($ | ) | ||||||||||
| $ | ||||||||||||
| * | For Unencumbered Projects other than Unstabilized Projects and Projects acquired after first day of applicable Fiscal Quarter |
| ** | For Unencumbered Projects that are Unstabilized Projects or are Projects acquired after first day of applicable Fiscal Quarter |
| *** | No individual Income-Producing Project may contribute more than 20% of the total amount of the Total Unencumbered Asset Value, as provided in the definition thereof. |
| **** | Unencumbered Projects not owned by Borrower or a Wholly-Owned Subsidiary in the aggregate cannot contribute more than 10% of the total amount of the Total Unencumbered Asset Value, as provided in the definition thereof. |
| ***** | Unstabilized Projects in the aggregate cannot contribute more than 10% of the total amount of the Total Unencumbered Asset Value, as provided in the definition thereof. |
| ****** | Unencumbered land parcels in the aggregate cannot contribute over 5% of the total amount of the Total Unencumbered Asset Value, as provided in the definition thereof. |
| ******* | Foreign Projects in the aggregate cannot contribute over 15% of the total amount of the Total Unencumbered Asset Value, as provided in the definition thereof. |
SCHEDULE 4.4
SUBSIDIARIES
| NAME OF SUBSIDIARY |
FORM OF LEGAL ENTITY |
OWNERSHIP |
JURISDICTION | |||
| 1. BioMed Realty, L.P. | Limited Partnership | 0.2% GP Interest by BioMed Realty Trust, Inc. 97.9% LP Interest by BioMed Realty Trust, Inc. 1.9% LP Interest by others |
Maryland | |||
| 2. BioMed Realty Holdings, Inc. |
Corporation | 100% by BioMed Realty, L.P. | Maryland | |||
| 3. BioMed Realty Trust, Inc. REIT Qualification Trust |
Trust | 100% Beneficiary is BioMed Realty Holdings, Inc. |
California | |||
| 4. BMR-GP LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 5. BioMed Realty LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 6. BioMed Realty Development LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 7. BMR-JV I Holdings LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 8. BMR-▇▇ ▇▇ Holdings LLC |
Limited Liability Company | 100% by BioMed Realty Holdings, Inc. |
Delaware | |||
| 9. BioMed Ventures LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 10. BMR LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 11. BMV Direct LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 12. BMR-217th Place LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 13. BMR-270 Albany Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 14. BMR-34790 Ardentech Court LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC 100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 15. ▇▇▇-▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. |
Delaware | |||
| 16. 34175 Ardenwood Venture, LLC |
Limited Liability Company | 87.5% Membership Interest by ▇▇▇-▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ LLC
12.5% Membership Interest |
Delaware | |||
| 17. BMR-Ardsley Park LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. |
Delaware | |||
| 18. ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. |
California | |||
| 19. BMR-Bayshore Boulevard LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by |
Delaware | |||
| 20. BMR-6411 ▇▇▇▇▇▇▇ Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. |
Delaware | |||
| 21. Guilford Real Estate Trust 1998-1 |
Grantor Trust | 100% Beneficiary is BioMed Realty, L.P., Trustee is BMR-6411 ▇▇▇▇▇▇▇ Street LLC |
Utah | |||
| 22. BMR-9900 Belward Campus LLC |
Limited Liability Company | 100% by BMR-9900 Belward Campus Holdings LLC |
Delaware | |||
| 23. BMR-9900 Belward Campus Borrower LLC |
Limited Liability Company | 100% by BMR-9900 Belward Campus Holdings LLC |
Delaware | |||
| 24. BMR-9900 Belward Campus Holdings LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. |
Delaware | |||
| 25. BMR-9901 Belward Campus LLC |
Limited Liability Company | 100% by BMR-9901 Belward Campus Holdings LLC |
Delaware | |||
| 26. BMR-9901 Belward Campus Borrower LLC |
Limited Liability Company | 100% by BMR-9901 Belward Campus Holdings LLC |
Delaware | |||
| 27. BMR-9901 Belward Campus Holdings LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. |
Delaware | |||
| 28. BMR-Belward Campus Drive LSM LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. |
Maryland | |||
| 29. BMR-9920 Belward Campus Q LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. |
Rhode Island | |||
| 30. ▇▇▇-▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 31. BMR-Blackfan Circle LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 32. BMR-Bridgeview LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 33. BMR-Bridgeview II LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 34. BMR-Broadway LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 35. BMR-550 Broadway LP (f/k/a BMR-▇▇▇▇ ▇▇) |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 36. BMR-Bunker ▇▇▇▇ ▇▇ |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 37. BMR-58 ▇▇▇▇▇▇▇ Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 38. BMR-134 ▇▇▇▇▇▇▇▇ Avenue LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 39. ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 40. BMR-350 E ▇▇▇▇▇▇▇ F LLC |
Limited Liability Company | 100% by BMR-PR II LLC | Delaware | |||
| 41. BMR-650 E ▇▇▇▇▇▇▇ B LLC |
Limited Liability Company | 100% by BMR-PR II LLC | Delaware | |||
| 42. BMR-475 Eccles Avenue LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 43. BMR-2600 Eisenhower Road LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 44. BMR-201 ▇▇▇▇▇▇▇ Avenue LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 45. BMR-21 Erie Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 46. BMR-40 Erie Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 47. BMR-Executive Drive LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 48. BMR-4570 Executive Drive LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 49. BMR-500 Fairview Avenue LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 50. BMR-530 Fairview Avenue LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 51. ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 52. BMR-Fresh Pond Research Park LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 53. BMR-700 Gateway LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 54. BMR-750,800,850 Gateway LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 55. BMR-900 Gateway LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 56. BMR-1000 Gateway LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 57. BMR-Gateway/Oyster LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 58. BMR-Gazelle LP | Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 59. BMR-350 ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Boulevard LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 60. Granta Park JCo 1 Limited |
Company Limited by Shares | 100% by BMR LLC | Jersey | |||
| 61. BMR-7 Graphics Drive LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 62. BMR-Hampshire LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 63. BMR-201 Industrial Road LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 64. BMR-3525 ▇▇▇▇ ▇▇▇▇▇▇▇ LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 65. BMR-3545-3575 ▇▇▇▇ ▇▇▇▇▇▇▇ LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 66. BMR-6500 ▇▇▇▇▇▇ Drive LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 67. BMR-450 ▇▇▇▇▇▇▇ Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 68. BMR-500 ▇▇▇▇▇▇▇ Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 69. BMR-▇▇▇▇▇▇▇ Development LLC |
Limited Liability Company | 100% by BMR-PR II TRS LLC | Delaware | |||
| 70. BMR-▇▇▇▇▇▇▇ Holdings LLC |
Limited Liability Company | 100% by BMR-PR II TRS LLC | Delaware | |||
| 71. BMR-145 King of Prussia Road GP LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 72. BMR-145 King of Prussia Road LP | Limited Partnership | 99.5% LP Interest by BioMed Realty, L.P.
0.5% GP Interest by BMR-145 King of Prussia Road GP LLC |
Delaware | |||
| 73. BMR-Landmark at Eastview LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 74. 10165 ▇▇▇▇▇▇▇▇ Court, L.P. |
Limited Partnership | 22% GP Interest by BMR-10165 ▇▇▇▇▇▇▇▇ Court GP LLC
78% LP Interest by Quidel Corporation |
California | |||
| 75. BMR-10165 ▇▇▇▇▇▇▇▇ Court GP LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | California | |||
| 76. BMR-Medical Center Drive LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 77. ▇▇▇-▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 78. BMR-6114-6154 ▇▇▇▇▇ ▇▇▇▇▇ Drive LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 79. BMR-6828 ▇▇▇▇▇ ▇▇▇▇▇ Drive LLC |
Limited Liability Company | 100% by BioMed Realty, L.P.
BioMed Realty LLC is Managing Member |
Delaware | |||
| 80. BMR-One Research Way LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 81. BMR-180 Oyster Point LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 82. BMR-200 Oyster Point LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 83. BMR-Pacific Center LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 84. BMR-Pacific Research Center LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 85. ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 86.BMR-Patriot LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 87. BMR-335-395 Phoenixville Pike LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 88. BMR-PR II LLC |
Limited Liability Company | 20% BMR-JV I Holdings LLC, 80% Prudential | Delaware | |||
| 89. BMR-PR II TRS LLC |
Limited Liability Company | 20% BMR-▇▇ ▇▇ Holdings LLC, 80% Prudential | Delaware | |||
| 90. BMR-Research Boulevard LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 91. BMR-Road to the Cure LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 92. BMR-▇▇▇▇▇▇ Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 93. BMR-10240 Science Center Drive LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 94. BMR-10255 Science Center LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 95. BMR-Shady Grove Road HQ LLC |
Limited Liability Company | 100% by BMR-Shady Grove Holdings LLC | Maryland | |||
| 96. BMR-Shady Grove Holdings LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 97. BMR-Shady Grove B LLC |
Limited Liability Company | 100% by BMR-Shady Grove Holdings LLC | Delaware | |||
| 98. BMR-Shady Grove D LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 99. BMR-200 ▇▇▇▇▇▇ Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 100. BMR-Sorrento Plaza LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 101. BMR-Sorrento Valley Boulevard LP | Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 102. BMR-11388 Sorrento Valley Road LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 103. BMR-Sorrento West LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 104. BMR-Spring Mill Drive GP LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 105. BMR-Spring Mill Drive, LP |
Limited Partnership | 1% GP Interest by BMR-Spring Mill Drive GP LLC 99% LP Interest by BioMed Realty, L.P.
|
Delaware | |||
| 106. BMR-▇▇▇▇▇▇▇ Ridge LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 107. BMR-Torreyana LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 108. BMR-9865 Towne Centre LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 109. BMR-9885 Towne Centre LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 110. BMR-Trade Centre Avenue LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 111. BMR-6611 Tributary Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Maryland | |||
| 112. BMR-900 Uniqema Boulevard LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 113. BMR-1000 Uniqema Boulevard LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 114. BMR-325 Vassar Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 115. ▇▇▇-▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ LLC | Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 116. BMR-▇▇▇▇▇▇ ▇▇ |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 117. BMR-Wateridge LP |
Limited Partnership | 0% GP Interest by BMR-GP LLC
100% LP Interest by BioMed Realty, L.P. |
Delaware | |||
| 118. BMR-675 ▇▇▇▇ ▇▇▇▇▇▇▇ Street LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 119. BMR-50 West ▇▇▇▇▇▇▇ Mill LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 120. BMR-West ▇▇▇▇▇▇▇ Mill LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
| 121. BMR-Weston LLC |
Limited Liability Company | 100% by BioMed Realty, L.P. | Delaware | |||
SCHEDULE 4.19
PROJECTS
| Property Name |
Ownership | |||
| 1. | ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇.▇. ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 2. | ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 3. | ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 4. | ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple* | ||
| 5. | Ardsley Park (410, 420, 430, 440, 444 and ▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇) |
Fee Simple | ||
| 6. | ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 7. | 3240, 3260, ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 8. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 9. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 10. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 11. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 12. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 13. | ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Leasehold Interest | ||
| 14. | ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Leasehold Interest | ||
| 15. | ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Leasehold Interest | ||
| Property Name |
Ownership | |||
| 16. | ▇▇▇▇▇▇▇ Crossing Apartments (157 Sixth Street Cambridge, Massachusetts 02142) |
Leasehold Interest | ||
| 17. | ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 18. | ▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 19. | ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇ (▇▇▇▇▇ Clawiter Road ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ 94545) |
Fee Simple | ||
| 20. | Bridgeview Technology Park II (▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇) |
Fee Simple | ||
| 21. | ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 22. | ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 23. | ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 24. | ▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 25. | ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 26. | ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 27. | ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple* | ||
| 28. | ▇▇▇ ▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple* | ||
| 29. | ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 30. | ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 31. | ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| Property Name |
Ownership | |||
| 32. | ▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 33. | ▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 34. | ▇▇ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 35. | 4775 and ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 36. | ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 37. | ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Leasehold Interest | ||
| 38. | ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 39. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 40. | Fresh Pond Research Park (25, 27/31, 33/45, 51 and ▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ and ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇) |
Fee Simple | ||
| 41. | ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 42. | 750, 800, and ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 43. | ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 44. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 45. | Pacific Research Center (7333, 7555, 7575, 7677, 7707, 7979, 7999, 7700, 7600, and ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇) |
Fee Simple | ||
| 46. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 47. | ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 48. | ▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| Property Name |
Ownership | |||
| 49. | ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇ |
Freehold Estate | ||
| 50. | ▇▇/▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 51. | ▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 52. | ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 53. | ▇▇▇▇-▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 54. | ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 55. | ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Leasehold Interest | ||
| 56. | ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 57. | ▇▇▇ ▇▇▇▇ ▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 58. | Landmark at Eastview (735, 745,755, 765, 767, 769, 771, ▇▇▇ ▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇., ▇▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇) (1 ▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇) |
Fee Simple | ||
| 59. | ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple* | ||
| 60. | 9704 and 9708 – ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 61. | ▇▇▇▇-▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 62. | 6114, 6118, 6122, 6124, 6126 and ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ | Fee Simple | ||
| 63. | ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 64. | ▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| Property Name |
Ownership | |||
| 65. | ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 66. | ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 67. | 5870 and ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 68. | ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 69. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 70. | ▇▇▇-▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 71. | 1701 and ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 72. | 10835 Road to the Cure ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 73. | ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 74. | ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 75. | ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 76. | ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 77. | 11404 and ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 78. | ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 79. | ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 80. | 11080, 11100, 11120 and ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ and 11055, 11095, 11111, 11125, and ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ | Fee Simple | ||
| 81. | ▇-▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| Property Name |
Ownership | |||
| 82. | 9965 – ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 83. | ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 84. | 9855 and ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 85. | 9875 and ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 86. | 2600 and ▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 87. | ▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 88. | ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 89. | ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 90. | ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 91. | ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 92. | 1825, 1865, ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇/ ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 93 | 10420, 10480, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 94. | ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇ |
Fee Simple | ||
| 95. | ▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 96. | 55 and ▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| 97. | ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ |
Fee Simple | ||
| * | Such properties are owned by Investment Affiliates of Borrower. |
